Clinical Trials on Glycogen Storage Disease
Total 379410 results
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Pompe DiseaseUnited States
-
Rigshospitalet, DenmarkCompletedGlycogen Storage Disease Type IIIDenmark
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Spain, Italy
-
Genzyme, a Sanofi CompanyRecruitingPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Glycogenesis 2 Acid Maltase DeficiencyCroatia, United States, Italy, Belgium, Czechia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Rigshospitalet, DenmarkUltragenyx Pharmaceutical IncCompletedTarui Disease | Debrancher Deficiency | GYG1 DEFICIENCYDenmark
-
University College, LondonCompleted
-
Institut de Myologie, FranceUnknownNeuromuscular DisordersFrance
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, Italy, Spain, Taiwan, United Kingdom, Netherlands, France, Germany
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type IIFrance
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIChina
-
Duke UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedGlycogen Storage Disease Type IIUnited States
-
Columbia UniversityWithdrawnGlycogen Storage Disease Type IIUnited States
-
University of FloridaAmicus TherapeuticsCompletedLysosomal Storage Diseases | Glycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingGlycogen Storage Disease Type II
-
Hong Kong Children's HospitalRecruitingGlycogen Storage Disease Type IBHong Kong
-
Duke UniversityRecruitingAdult Polyglucosan Body Disease | Glycogen Storage Disease Type IV | GSD4 | GSD IV | APBDUnited States
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Netherlands
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, China, Germany, Italy, Netherlands, Spain, Taiwan, United Kingdom
-
Taipei Veterans General Hospital, TaiwanUnknownGlycogen Storage Disease Type IITaiwan
-
Centre Hospitalier de CayenneCompleted
-
Amicus TherapeuticsRecruitingPompe DiseaseUnited States
-
Duke UniversitySanofiRecruiting
-
Duke UniversityGenzyme, a Sanofi CompanyRecruitingPompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Valerion Therapeutics, LLCTerminatedPompe DiseaseUnited States, United Kingdom
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)CompletedPompe DiseaseUnited States
-
BioMarin PharmaceuticalCompletedPompe DiseaseUnited States, United Kingdom, France, Australia, Germany
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
University of FloridaCompletedPompe DiseaseUnited States
-
National Taiwan University HospitalUnknown
-
Genzyme, a Sanofi CompanyTerminatedPompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, Taiwan, Israel, United Kingdom, France
-
National Institute of Arthritis and Musculoskeletal...CompletedMyositis | Dermatomyositis | Polymyositis | Glycogen Storage Disease Type II | Glycogen Storage Disease Type VIIUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2United States, France, Netherlands
-
Genzyme, a Sanofi CompanyActive, not recruiting
-
Centre Hospitalier de CayenneCompleted
-
University of AarhusUnknownGlycogen Storage Disease Type 2 | Dystrophia MyotonicaDenmark
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2Netherlands
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France
-
Serhat Gumrukcu, MD PhDFrida Therapeutics LLCRecruiting
-
Amicus TherapeuticsAvailable
-
Duke UniversityCompleted
-
Duke UniversityGenzyme, a Sanofi CompanyCompleted
-
Duke UniversityCompletedPompe DiseaseUnited States
-
Duke UniversityCompleted
-
Dwight Koeberl, M.D., Ph.D.Completed